We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urinary Test Score Unchanged by Chronic Prostatitis

By LabMedica International staff writers
Posted on 25 Apr 2012
Print article
The influence of chronic prostatitis on the potential new biomarkers of prostate cancer (PCa) found in male urinary samples has been determined.

Prostate cancer gene 3 (PCA3) is one of the most promising candidate markers for prostate cancer (PCa) diagnosis and it has been found to be overexpressed in up to 95% of all prostate cancer patients tested and is 60- to 100-less expressed in noncancerous than in cancerous tissues.

Scientists the Hospices Civils de Lyon (France) collected urine specimens for cytological analysis and culture from 38 patients with clinical suspicion of chronic prostatitis whose mean-age was 37.5 years. The specimens were collected between March and June 2010 and a postprostatic massage urine sample was used for the urinary PCA3 test. None of the patients had history of prostate cancer.

The PCA3 and Prostate Specific Antigen (PSA) ribonucleic acid (RNA) were quantified in parallel using the Progensa PCA3 Assay (Gen-Probe; San Diego, CA, USA). Urine samples were considered as noninformative for prostate cells if number of PSA messenger RNA (mRNA) transcripts detected was less than 10,000. A negative PCA3 test was considered if PCA3 score was less than the usual cutoff of 35. The PCA3 test was considered positive if PCA3 score was higher than or equal to 35.

Four patients had an eventual diagnosis of urethritis and all had a PCA3 score less than 5. Among the remaining 34 patients, seven had bacterial chronic prostatitis, 11 had abacterial chronic prostatitis, and 16 had noninflammatory prostatodynia. All these patients had a PCA3 score less than 28, that is, under the cutoff of 35, which is commonly used for prostate cancer diagnosis.

The authors concluded that prostate massage included within the Meares–Stamey four-glass localization test allows informative samples for urinary PCA3 test. The PCA3 score was found to be negative with less than the usual cutoff of 35, in all tested patients, suggesting that PCA3 test can be used as a valuable tool in patients with raised PSA and suspicion of chronic prostatitis to distinguish those patients who will really benefit from prostate biopsy. The study was published in the April 2012 edition of the journal the Prostate.

Related Links:

Hospices Civils de Lyon
Gen-Probe



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.